ArticleAnimal microbiome2026
Lactobacillus plantarum (LPsca12) enhances growth phenotype and muscle nutrition in abalone (Haliotis discus hannai) by modulating microbial function and metabolism through the Amino Acid-Driven Gut-Muscle Axis.
Article in Animal microbiome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWith the continuous expansion of abalone (Haliotis discus hannai) aquaculture, improving growth rate and muscle quality has become an increasingly important concern. Probiotic supplementation represents a promising strategy; however, the effects of probiotics on abalone remain poorly understood, particularly concerning their mechanisms of action on muscle physiology. This study employed a multi-omics investigation to explore the impact of the Lactobacillus plantarum (LPsca12) strain on hepatic metabolism and gut microbiota composition in abalone, and the potential associations between intestinal metabolites and short-chain fatty acids (SCFAs) in muscle.
resultsOur findings reveal that (I) probiotic supplementation induced notable shifts in gut microbiota composition, thereby enhancing abalone growth performance and reducing lipid accumulation by promoting hepatic lipid metabolism, (II) reshaped microbial community strongly linked to elevated concentrations of key amino acids in abalone, including L-leucine, L-isoleucine, L-valine, and L-arginine, which are considered potential precursors for SCFAs production, and (III) the elevated levels of SCFAs, such as acetate and propionate, in muscle tissue may activate the mTORC1 signaling pathway, thereby promoting protein synthesis and improving the nutritional status of abalone muscle.
conclusionsThe results indicate that LPsca12 exerts beneficial effects on abalone by enhancing growth performance and improving lipid metabolism and promoting muscle nutritional status through an amino acid-driven gut–muscle axis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.